1. Deferasirox chelation therapy in patients with transfusion‐dependent MDS: a 'real‐world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata. (12th March 2015) Authors: Maurillo, Luca; Breccia, Massimo; Buccisano, Francesco; Voso, Maria Teresa; Niscola, Pasquale; Trapè, Giulio; Tatarelli, Caterina; D'Addosio, Ada; Latagliata, Roberto; Fenu, Susanna; Piccioni, Anna Lina; Fragasso, Alberto; Aloe Spiriti, Maria A.; Refrigeri, Marco; Criscuolo, Marianna; Musto, Pell... Journal: European journal of haematology Issue: Volume 95:Number 1(2015:Jul.) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?. (January 2019) Authors: Di Veroli, Ambra; Campagna, Alessia; De Muro, Marianna; Maurillo, Luca; Trawinska, Malgorzata Monika; LeonettiCrescenzi, Sabrina; Petriccione, Luca; Romano, Atelda; D'Addosio, Ada; Cenfra, Antonia; Montanaro, Marco; Felici, Stefano; Andriani, Alessandro; Carmosino, Ida; Niscola, Pasquale; Montefu... Journal: Leukemia research Issue: Volume 76(2019) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗